• 20469 Citations
  • 66 h-Index
1981 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea

Kim, S. U., Seo, Y. S., Lee, H. A., Kim, M. N., Lee, Y. R., Lee, H. W., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Hwang, S. G., Rim, K. S., Um, S. H., Tak, W. Y., Kweon, Y. O., Kim, B. K. & Park, S. Y., 2019 Sep, In : Journal of Hepatology. 71, 3, p. 456-464 9 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)
Open Access
1 Citation (Scopus)
Open Access
1 Citation (Scopus)

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database

Lee, J. S., Cho, I. R., Lee, H. W., Jeon, M. Y., Lim, T. S., Baatarkhuu, O., Kim, D. Y., Han, K. H. & Park, J. Y., 2019 Oct 1, In : Cancer research and treatment : official journal of Korean Cancer Association. 51, 4, p. 1347-1356 10 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation

Kim, C. G., Lee, H. W., Choi, H. J., Lee, J. I., Lee, H. W., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Kim, H. S., Kim, K. H., Choi, S. J., Kim, Y., Lee, K. S., Kim, G. M., Kim, M. D., Won, J. Y., Lee, D. Y. & Kim, B. K., 2019 Sep 1, In : Cancer medicine. 8, 11, p. 5023-5032 10 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Development of a new nomogram including neutrophil-to-lymphocyte ratio to predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Chon, Y. E., Park, H., Hyun, H. K., Ha, Y., Kim, M. N., Kim, B. K., Lee, J. H., Kim, S. U., Kim, D. Y., Ahn, S. H., Hwang, S. G., Han, K. H., Rim, K. S. & Park, J. Y., 2019 Apr, In : Cancers. 11, 4, 509.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
1 Citation (Scopus)

Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection

Ahn, S. H., Kim, W., Jung, Y. K., Yang, J. M., Jang, J. Y., Kweon, Y. O., Cho, Y. K., Kim, Y. J., Hong, G. Y., Kim, D. J., Um, S. H., Sohn, J. H., Lee, J. W., Park, S. J., Lee, B. S., Kim, J. H., Kim, H. S., Yoon, S. K., Kim, M. Y., Yim, H. J. & 8 others, Lee, K. S., Lim, Y. S., Lee, W. S., Park, N. H., Jin, S. Y., Kim, K. H., Choi, W. & Han, K. H., 2019 Aug, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1850-1859.e4

Research output: Contribution to journalArticle

Open Access
6 Citations (Scopus)

Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells

König, A., Yang, J., Jo, E., Park, K. H. P., Kim, H., Than, T. T., Song, X., Qi, X., Dai, X., Park, S., Shum, D., Ryu, W. S., Kim, J. H., Yoon, S. K., Park, J. Y., Ahn, S. H., Han, K. H., Gerlich, W. H. & Windisch, M. P., 2019 Aug, In : Journal of Hepatology. 71, 2, p. 289-300 12 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)

External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy

Lee, H. W., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H. & Kim, B. K., 2019 Sep 1, In : Liver International. 39, 9, p. 1624-1630 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Park, Y., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Yeon, J. E., Byun, K. S., Kim, H. S., Kim, J. H. & Kim, S. U., 2019 Apr 16, In : BMC cancer. 19, 1, 363.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers

Kim, H. S., Baatarkhuu, O., Lee, H. W., Park, J. Y., Kim, D. Y., Ahn, S. H., Song, K., Han, K. H., Kim, B. K. & Kim, S. U., 2019 Jan, In : Liver International. 39, 1, p. 81-89 9 p.

Research output: Contribution to journalArticle

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

Kim, D. S., Jeon, M. Y., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H. & Kim, S. U., 2019 Sep, In : Clinical and Molecular Hepatology. 25, 3, p. 283-293 11 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Liver cirrhosis, not antiviral therapy, predicts clinical outcome in cohorts with heterogeneous hepatitis B viral status

Kim, M. N., Hwang, S. G., Kim, B. K., Park, J. Y., Kim, D. Y., Han, K. H., Kim, S. U. & Ahn, S. H., 2019 Mar, In : Gut and liver. 13, 2, p. 197-205 9 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)

Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients

Baik, M., Kim, S. U., Kang, S., Park, H. J., Nam, H. S., Heo, J. H., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Lee, H. S. & Kim, Y. D., 2019 Apr 1, In : Cerebrovascular Diseases. 47, 1-2, p. 32-39 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis

Kim, M. N., Kim, B. K., Kim, S. U., Park, J. Y., Ahn, S. H., Han, K. H. & Kim, D. Y., 2019 Oct 3, In : Scandinavian Journal of Gastroenterology. 54, 10, p. 1283-1290 8 p.

Research output: Contribution to journalArticle

Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection

Lee, H. W., Park, J. Y., Lee, J. W., Yoon, K. T., Kim, C. W., Park, H., Kim, Y. S., Paik, S. K., Lee, J. I., Kim, B. K., Han, K. H. & Ahn, S. H., 2019 Jun, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1348-1355.e2

Research output: Contribution to journalArticle

5 Citations (Scopus)

Multicenter retrospective risk assessment of esophageal variceal bleeding in patients with cirrhosis: An acoustic radiation force impulse elastography-based prediction model

Heo, J. Y., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Tak, W. Y., Kweon, Y. O., Han, K. H., Park, S. Y. & Kim, S. U., 2019 Mar, In : Gut and liver. 13, 2, p. 206-214 9 p.

Research output: Contribution to journalArticle

Open Access

Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma

Kim, J. W., Kim, D. Y., Han, K. H. & Seong, J., 2019 Mar, In : Digestive and Liver Disease. 51, 3, p. 445-451 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy

Lee, H. W., Na, K., Kim, S. U., Kim, B. K., Park, J. Y., Nahm, J. H., Lee, J. I., Kim, D. Y., Ahn, S. H., Han, K. H. & Park, Y. N., 2019 Dec 1, In : Scientific reports. 9, 1, 15628.

Research output: Contribution to journalArticle

Open Access
Open Access

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

Jeon, M. Y., Kim, H. S., Lim, T. S., Han, D. H., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Choi, G. H., Choi, J. S., Han, K. H. & Kim, S. U., 2019 Apr, In : PloS one. 14, 4, e0214613.

Research output: Contribution to journalArticle

Open Access

Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma

Kim, N., Kim, H. J., Won, J. Y., Kim, D. Y., Han, K. H., Jung, I. & Seong, J., 2019 Feb, In : Radiotherapy and Oncology. 131, p. 81-87 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Strahlentherapie-Dosiseskalation nach unvollständiger transarterieller Chemoembolisation bei hepatozellulärem Karzinom

Translated title of the contribution: Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinomaByun, H. K., Kim, H. J., Im, Y. R., Kim, D. Y., Han, K. H. & Seong, J., 2019 Jan 1, In : Strahlentherapie und Onkologie.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis

Kim, D. S., Lim, T. S., Jeon, M. Y., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Baatarkhuu, O. & Kim, S. U., 2019 Dec 1, In : Digestive diseases and sciences. 64, 12, p. 3660-3668 9 p.

Research output: Contribution to journalArticle

Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

Evans, T. R. J., Kudo, M., Finn, R. S., Han, K. H., Cheng, A. L., Ikeda, M., Kraljevic, S., Ren, M., Dutcus, C. E., Piscaglia, F. & Sung, M. W., 2019 Jul 30, In : British journal of cancer. 121, 3, p. 218-221 4 p.

Research output: Contribution to journalArticle

Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy

Kim, S. U., Seo, Y. S., Lee, H. A., Kim, M. N., Kim, E. H., Kim, H. Y., Lee, Y. R., Lee, H. W., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Hwang, S. G., Rim, K. S., Um, S. H., Tak, W. Y., Kweon, Y. O., Kim, B. K. & Park, S. Y., 2019 Jan 1, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2018

Combination of transient elastography and an enhanced liver fibrosis test to assess the degree of liver fibrosis in patients with chronic hepatitis B

Heo, J. Y., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, H. S., Park, Y. N., Han, K. H., Song, K. & Kim, S. U., 2018 Mar, In : Gut and liver. 12, 2, p. 190-200 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Daclatasvir plus asunaprevir for the treatment of patients with hepatitis C virus genotype 1b infection: Real-world efficacy, changes in liver stiffness and fibrosis markers, and safety

Lee, H. W., Oh, S. R., Kim, D. Y., Jeong, Y., Kim, S., Kim, B. K., Kim, S. U., Kim, D. Y., Ahn, S. H., Han, K. H. & Park, J. Y., 2018 May, In : Gut and liver. 12, 3, p. 324-330 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Chong, J. U., Choi, G. H., Han, D. H., Kim, K. S., Seong, J., Han, K. & Choi, J. S., 2018 Oct 1, In : Annals of Surgical Oncology. 25, 11, p. 3308-3315 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis

Jang, J. W., Choi, J. Y., Kim, Y. S., Yoo, J. J., Woo, H. Y., Choi, S. K., Jun, C. H., Lee, C. H., Sohn, J. H., Tak, W. Y., Lee, Y. R. & Han, K. H., 2018 Dec, In : Clinical Gastroenterology and Hepatology. 16, 12, p. 1954-1963.e3

Research output: Contribution to journalArticle

9 Citations (Scopus)

Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures

Jeong, Y., Jin, B., Lee, H. W., Park, H. J., Park, J. Y., Kim, D. Y., Han, K. H., Ahn, S. H. & Kim, S., 2018 Nov, In : Journal of Viral Hepatitis. 25, 11, p. 1251-1259 9 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B

Jeon, M. Y., Lee, H. W., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., Han, K. H. & Ahn, S. H., 2018 Apr, In : Liver International. 38, 4, p. 676-686 11 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
3 Citations (Scopus)

HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China

Wei, L., Omata, M., Lim, Y. S., Xie, Q., Hou, J. L., Jia, J., Hedskog, C., Martin, R., Doehle, B., Yang, J., De-Oertel, S., Massetto, B., Kersey, K., Brainard, D. M., Svarovskaia, E., Mo, H., Han, K. H., Mizokami, M. & Duan, Z., 2018 Oct, In : Antiviral Research. 158, p. 178-184 7 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement

Karlas, T., Petroff, D., Sasso, M., Fan, J. G., Mi, Y. Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K. H., Cardoso, A. C., Ferraioli, G., Chan, W. K., Wong, V. W. S., Myers, R. P., Chayama, K., Friedrich-Rust, M., Beaugrand, M., Shen, F., Hiriart, J. B., Sarin, S. K. & 12 others, Badea, R., Lee, H. W., Marcellin, P., Filice, C., Mahadeva, S., Wong, G. L. H., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V. & Wiegand, J., 2018 Apr, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 989-1000 12 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Kudo, M., Finn, R. S., Qin, S., Han, K. H., Ikeda, K., Piscaglia, F., Baron, A., Park, J. W., Han, G., Jassem, J., Blanc, J. F., Vogel, A., Komov, D., Evans, T. R. J., Lopez, C., Dutcus, C., Guo, M., Saito, K., Kraljevic, S., Tamai, T. & 2 others, Ren, M. & Cheng, A. L., 2018 Mar 24, In : The Lancet. 391, 10126, p. 1163-1173 11 p.

Research output: Contribution to journalArticle

501 Citations (Scopus)
7 Citations (Scopus)

Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

Chon, Y. E., Jung, K. S., Kim, M. J., Choi, J. Y., An, C., Park, J. Y., Ahn, S. H., Kim, B. K., Kim, S. U., Park, H., Hwang, S. K., Rim, K. S., Han, K. H. & Kim, D. Y., 2018 Apr, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1201-1212 12 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
6 Citations (Scopus)

Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib

Jeon, M. Y., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K. H., Baek, S. E., Kim, H. S., Kim, S. U. & Park, M. S., 2018 Sep, In : Liver International. 38, 9, p. 1655-1663 9 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patients

Chuang, W. L., Jia, J., Chan, H. L. Y., Han, K. H., Tanwandee, T., Tan, D., Chen, X., Gane, E., Piratvisuth, T., Chen, L., Xie, Q., Sung, J. J. Y., Messinger, D., Wat, C., Bakalos, G. & Liaw, Y. F., 2018 May, In : Alimentary Pharmacology and Therapeutics. 47, 9, p. 1306-1316 11 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study

Kwon, J. H., Kim, G. M., Han, K., Won, J. Y., Kim, M. D., Lee, D. Y., Lee, J., Choi, W., Kim, Y. S., Kim, D. Y. & Han, K. H., 2018 Mar 1, In : Cardiovascular and interventional radiology. 41, 3, p. 459-465 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B

Han, E., Lee, Y. H., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B. W., Kang, E. S., Cha, B. S., Han, K. H. & Kim, S. U., 2018 Aug, In : Alimentary Pharmacology and Therapeutics. 48, 3, p. 300-312 13 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Serotonin signals through a gut-liver axis to regulate hepatic steatosis

Choi, W., Namkung, J., Hwang, I., Kim, H., Lim, A., Park, H. J., Lee, H. W., Han, K. H., Park, S., Jeong, J. S., Bang, G., Kim, Y. H., Yadav, V. K., Karsenty, G., Ju, Y. S., Choi, C., Suh, J. M., Park, J. Y., Park, S. & Kim, H., 2018 Dec 1, In : Nature communications. 9, 1, 4824.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection

Younossi, Z. M., Stepanova, M., Henry, L., Han, K. H., Ahn, S. H., Lim, Y. S., Chuang, W. L., Kao, J. H., Nguyen, K. V., Lai, C. L., Chan, H. L. Y. & Wei, L., 2018 Dec, In : Journal of Viral Hepatitis. 25, 12, p. 1429-1437 9 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
6 Citations (Scopus)